GEN Exclusives

More »

GEN News Highlights

More »
Mar 2, 2007

Cegedim to Pick Up Dendrite for $751M

  • Cegedim, French maker of software for the life sciences industry, will spend $751 million for Dendrite International to expand the reach of its services into the U.S. and Asia-Pacific region.

    The offering of $16 per share represents a 25% premium over Dendrite’s closing price the day before the proposal. Dendrite opened trading at $15.61.

    Cegedim expects the combined company to have estimated pro forma annual revenues of $1.1 billion and operate in more than 75 countries across Europe, the Americas, and Asia-Pacific.

    "We are very excited to join forces with Dendrite's talented team to create a truly global business with increased international reach, a broader scope of product offerings, and the strength to invest in the development of innovative technologies," remarks Jean-Claude Labrune, founder, chairman, and CEO of Cegedim.


GEN Jobs powered by connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

Be sure to take the GEN Poll

Disclosing Clinical Trial Data

Do you believe that conducting performance audits for new drugs will incentivize pharma firms to become more transparent?

More »